Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip Fracture
Open Access
- 1 April 2010
- journal article
- conference paper
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (4), 650-657
- https://doi.org/10.1111/j.1532-5415.2010.02769.x
Abstract
OBJECTIVES: Although osteoporosis treatment can dramatically reduce fracture risk, rates of treatment after hip fracture remain low. In‐hospital initiation of recommended medications has improved outcomes in heart disease; hospitalization for hip fracture may represent a similar opportunity for improvement. The objective of this study was to examine rates of in‐hospital treatment with a combination of calcium and vitamin D (Cal+D) and antiresorptive or bone‐forming medications in patients hospitalized for hip fractures DESIGN: Observational cohort. SETTING: Three hundred eighteen hospitals in the United States. PARTICIPANTS: Fifty‐one thousand three hundred forty‐six patients aged 65 and older hospitalized for osteoporotic hip fracture. MEASUREMENTS: In‐hospital administration of Cal+D and antiresorptive or bone‐forming medications. RESULTS: Three thousand four hundred five patients (6.6%) received Cal+D anytime after a procedure to correct femoral fracture; 3,763 patients (7.3%) received antiresorptive or bone‐forming medications. Only 1,023 patients (2.0%) were prescribed ideal therapy, receiving Cal+D and an antiresorptive or bone‐forming medication. Treatment rates remained low across virtually all patient‐, provider‐, and hospital‐level characteristics. The strongest predictor of treatment with Cal+D was the receipt of an antiresorptive or bone‐forming medication (adjusted odds ratio=5.50, 95% confidence interval=4.84–6.25), but only 27.2% of patients who received these medications also received Cal+D. CONCLUSION: Rates of in‐hospital initiation of osteoporosis treatment for patients with hip fracture are low and may represent an opportunity to improve care.Keywords
This publication has 42 references indexed in Scilit:
- The relation between bisphosphonate use and non-union of fractures of the humerus in older adultsOsteoporosis International, 2008
- Do patients perceive a link between a fragility fracture and osteoporosis?BMC Musculoskeletal Disorders, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Risk of Subsequent Fracture After Low-Trauma Fracture in Men and WomenJama-Journal Of The American Medical Association, 2007
- Patient Adherence to Osteoporosis MedicationsDrugs & Aging, 2007
- The Treatment of Hip FracturesClinical Orthopaedics and Related Research, 2006
- A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repairJournal of Orthopaedic Research, 2005
- Importance of in-hospital initiation of evidence-based medical therapies for heart failure—a reviewThe American Journal of Cardiology, 2004
- Osteoporosis Prevention, Diagnosis, and TherapyJama-Journal Of The American Medical Association, 2001
- Modelling multivariate binary data with alternating logistic regressionsBiometrika, 1993